Back to search

Article

miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy

2021-09-09

Abstract excerpt

<title>Abstract</title> <p>Background Accumulating evidences reveal that aberrant microRNAs (miRNAs) expression can affect the development of chemotherapy drug resistance by modulating the expression of relevant target proteins. Emerging evidences have demonstrated that miR-133a participates in tumorigenesis of various cancers. However, whether miR-133a is associated with cisplatin resistance in ovarian cancer r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e54b117b-23c3-5771-a240-233e0f35b940
DOI
10.21203/rs.3.rs-861069/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagyDOI 10.21203/rs.3.rs-861069/v1
Select a neighboring publication to make it the new centre.